The molecular events driving c-Src activation in breast cancers are unclear although this can occur downstream of activated receptor tyrosine kinases (RTKs) including HER2/erbB2 (Muthuswamy et al, 1994; Belsches-Jablonski et al, 2001). This evidence concerns the gene ERBB2 and breast carcinoma.